US FDA consults on creating external expert network for emerging medical devices
This article was originally published in SRA
The US Food and Drug Administration has set in motion plans to create a network of external scientific experts that its devices unit can use to gain faster access to specialised knowledge about emerging technologies and other topics1.
You may also be interested in...
Five new drugs have been recommended for EU approval at the latest meeting of European Medicines Agency’s drug evaluation committee.
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.